checkpoint inhibitors
Tislelizumab Vies for First-Line Designation in Treatment of Advanced HCC
The checkpoint inhibitor tislelizumab might reasonably be considered a better choice for hepatocellular carcinoma ...
OCTOBER 20, 2023
Can Immunotherapy Help Some Patients With Colorectal Cancer Avoid Surgery?
Some patients with CRC have mismatch repair deficiency, making them less responsive to conventional chemotherapy ...
MAY 29, 2023
Flexible Sigmoidoscopy Is Diagnostic For Immunotherapy-Related Colitis
Flexible sigmoidoscopy may be sufficient for confirming colitis due to checkpoint inhibitor therapy, according to a ...
MARCH 4, 2022
Treatments for Immunotherapy-Induced Colitis Might Affect Cancer Outcomes
Biologic agents commonly used to treat gastrointestinal problems associated with the use of immune checkpoint ...
NOVEMBER 10, 2021
Checkpoint Inhibitors Appear to Threaten Liver Grafts
Liver transplant patients who receive checkpoint inhibitors for the treatment of cancer may be at increased risk ...
AUGUST 26, 2020
Checkpoint Inhibitors Advancing in Multiple GI Cancers
Immunotherapy with checkpoint inhibitors, specifically agents targeting programmed death-1 (PD-1), are advancing in ...
MAY 19, 2017
